Prosthetics & Orthotics
The U.S. prosthetics and orthotics market is growing with rising limb-loss prevalence, increasing musculoskeletal disorders, and wider adoption of lightweight, customized, and digitally enabled devices. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across upper- and lower-limb prosthetics, orthopedic braces, spinal orthoses, and smart mobility solutions.
The U.S. Robotic Prosthetics and Orthotics Market expands from USD 1.94 billion in 2026 to USD 3.42 billion by 2032 at a 9.94% CAGR. Growth is driven by diabetes-related lower-extremity amputations, targeted muscle reinnervation, expanding Medicare exoskeleton reimbursement, and the clinical transition from passive mechanical braces to active, AI-driven bionic limbs and powered neuro-rehabilitation orthoses across outpatient networks.
Read Report Details
The U.S. AI-enabled prosthetics and orthotics market is projected to expand from USD 2.97 billion in 2026 to USD 6.48 billion by 2032 at a 13.82% CAGR. Growth is fueled by increasing dysvascular amputations, landmark Medicare coverage expansions for K2 ambulators, neural-machine interface integration, and the clinical adoption of smart robotic exoskeletons across inpatient and home rehabilitation.
Read Report Details
The U.S. 3D printed prosthetics and orthotics market is projected to expand from USD 2.11 billion in 2026 to USD 4.24 billion by 2032, advancing at a 12.33% CAGR. Growth is fueled by accelerating diabetic amputations, certified clinician shortages, Medicare L-code reimbursement clarity, and the clinical transition from manual plaster casting to rapid, patient-specific additive digital fabrication workflows.
Read Report Details
The U.S. Digital Prosthetics and Orthotics Market is advancing rapidly from manual plaster casting to integrated 3D scanning, AI-driven CAD/CAM design, and additive manufacturing. Supported by expanding Medicare reimbursement for microprocessor knees, high dysvascular amputation rates, and a shortage of manual fabrication technicians, the market provides decisive clinical workflow acceleration, superior residual limb fit, and enhanced patient mobility outcomes nationwide.
Read Report Details
The U.S. smart prosthetics and orthotics market is projected to expand from USD 2.01 billion in 2026 to USD 3.42 billion by 2032 at a 9.28% CAGR. Growth is driven by expanding dysvascular amputee populations, CMS coverage modernizations for K2 ambulators, targeted muscle reinnervation adoption, and breakthrough innovations in microprocessor-controlled lower-extremity bionics, myoelectric pattern recognition, and powered wearable robotic exoskeletons.
Read Report Details
The U.S. patient-specific prosthetics and orthotics market is projected to grow from USD 4.50 billion in 2026 to USD 6.48 billion by 2032 at a 6.28% CAGR. Growth is driven by diabetes-related lower-limb amputations, an aging demographic, and the clinical transition from manual plaster casting to non-contact 3D scanning, cloud-based CAD/CAM design, and industrial additive manufacturing.
Read Report Details
The U.S. Custom Prosthetics and Orthotics Market is expected to expand robustly from $6.27 billion in 2026 to $9.54 billion by 2032, fueled by a 7.24% CAGR. Growth is primarily driven by the escalating prevalence of diabetic amputations, technological advancements in 3D-printed digital workflows, and expanded Medicare coverage for microprocessor bionic devices, shifting the landscape toward integrated digital rehabilitation.
Read Report Details
The U.S. Advanced Prosthetics and Orthotics Market is projected to grow from USD 6.22 billion in 2026 to USD 10.45 billion by 2032 at a 9.03% CAGR. Growth is driven by rising diabetic amputations, trauma caseloads, expanded Medicare coverage for microprocessor systems, 3D printing adoption, and high clinical demand across specialized outpatient rehabilitation facilities.
Read Report Details
The U.S. Orthotic Devices Market is projected to grow from USD 4.74 billion in 2026 to USD 7.28 billion by 2032 at a 7.42% CAGR. Expansion is driven by demographic aging, rising diabetes-related neuropathy, and continuous digital transformation spanning additive manufacturing, dynamic carbon composites, and stance-control lower-extremity bracing.
Read Report Details
The U.S. prosthetic devices market is projected to expand from USD 2.85 billion in 2026 to USD 4.52 billion by 2032, advancing at an 8.00% CAGR. Growth is fueled by an aging population, rising dysvascular amputations from diabetes, modernized Medicare reimbursement for microprocessor knees, and rapid clinical adoption of myoelectric bionic limbs, osseointegration, and 3D digital socket fabrication.
Read Report Details